Clinical Trial Update: A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating on the use of N-acetylcysteine (N-AC) in patients receiving CAR T-cell therapy for lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• N-Acetylcysteine (N-AC) (N-acetylcysteine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING